Nanohale AG (ETR:FYB) | WebDisclosure

PRESS RELEASE

published on 01/20/2025 at 06:30, 1 year 5 months ago

Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama®
Formycon receives EU approval for biosimilar FYB203 (aflibercept) to Eylea®, brands AHZANTIVE® and Baiama® for nAMD and retinal diseases. Teva to market AHZANTIVE® in Europe

Biosimilar Formycon EU Approval AHZANTIVE Baiama
BRIEF

published on 01/15/2025 at 06:35, 1 year 5 months ago

MHRA Grants Approval for Formycon and Fresenius Kabi's Otulfi®

Formycon Fresenius Kabi Ustekinumab Biosimilar Approval Otulfi® Launch
BRIEF

published on 01/15/2025 at 06:35, 1 year 5 months ago

La MHRA accorde son approbation à Formycon et à Otulfi® de Fresenius Kabi

Formycon Fresenius Kabi Ustekinumab Approbation Des Biosimilaires Lancement D'Otulfi®
PRESS RELEASE

published on 01/15/2025 at 06:30, 1 year 5 months ago

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi®, a biosimilar to Stelara®, for various inflammatory diseases. Global biosimilar approval news

Biosimilar Formycon Fresenius Kabi FYB202 MHRA Approval
BRIEF

published on 01/13/2025 at 07:05, 1 year 5 months ago

Teva Partners with Formycon for FYB203 Biosimilar in Europe and Israel

Biosimilars Formycon Teva FYB203 Europe And Israel
BRIEF

published on 01/13/2025 at 07:05, 1 year 5 months ago

Teva s'associe à Formycon pour le biosimilaire FYB203 en Europe et en Israël

Formycon Biosimilaires Teva FYB203 L'Europe Et Israël
PRESS RELEASE

published on 01/13/2025 at 07:00, 1 year 5 months ago

Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel
Teva partners with Formycon for commercialization of biosimilar FYB203 (Eylea®) in Europe and Israel, aiming to expand access to innovative medicines

Biosimilar Formycon Teva FYB203 Eylea
BRIEF

published on 01/09/2025 at 15:35, 1 year 5 months ago

Formycon Joins TecDAX Index

Stock Market Biosimilars Deutsche Börse TecDax Formycon
BRIEF

published on 01/09/2025 at 15:35, 1 year 5 months ago

Formycon rejoint l'indice TecDAX

Bourse TecDax Formycon Biosimilaires Bourse Allemande
PRESS RELEASE

published on 01/09/2025 at 15:30, 1 year 5 months ago

Formycon included in TecDAX Index of Deutsche Börse
Formycon AG to be included in TecDAX Index of Deutsche Börse, enhancing visibility and market position. Company specializes in biosimilars for various disease areas

Formycon AG Biosimilars Deutsche Börse TecDAX Index Technology Stocks

Published on 06/27/2026 at 16:50, 1 day 15 hours ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 6 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 8 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 9 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 2 days 9 hours ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/29/2026 at 08:05, 11 minutes ago

Update on voluntary public offer by NNS for OCI
Published on 06/29/2026 at 08:00, 16 minutes ago

MHM Corporate - Assemblée générale du 30 juin 2026 : Réunion probablement en 2ème convocation
Published on 06/29/2026 at 08:00, 16 minutes ago

MHM Corporate - General Meeting of June 30, 2026: likely to be held on second call due to lack of quorum
Published on 06/29/2026 at 08:00, 16 minutes ago

Transaction in Own Shares
Published on 06/29/2026 at 08:00, 16 minutes ago

Aquis Stock Exchange: Updated Application for Admission Announcement

View all EQS

Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 14 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 2 days 17 hours ago

Safran information
Published on 06/26/2026 at 14:44, 2 days 17 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News